Skip to main content
Top
Published in: BMC Geriatrics 1/2023

Open Access 01-12-2023 | Hyponatremia | Research

Serum sodium improvement: change in Comprehensive Geriatric Assessment parameters in geriatric patients with hyponatremia

Authors: M. Kapoor, M. Pathania, M. Dhar

Published in: BMC Geriatrics | Issue 1/2023

Login to get access

Abstract

Background

Hyponatremia presents with symptoms considered age-associated in the elderly. We assess the change in Comprehensive Geriatric Assessment (CGA) parameters after hyponatremia improvement in hospitalized geriatric patients.

Methods

We took 100 hyponatremic and same number of eunatremic geriatric patients (> 60 years) who were comorbidity, presenting-complaints, and age-matched. Four CGA parameters were utilized, the new Hindi Mental State Examination (HMSE), Barthel’s index of activities of daily living (ADL), Timed up and go Test (TUG), and handgrip strength by hand dynamometer (HG). We analyzed these at admission and discharge, and their relationship with change in sodium levels.

Results

Average age was 68.1 ± 5.8 years, with males constituting 75%. The CGA parameters demonstrated worse values amongst the hyponatremia than the normonatremia group. Severe hyponatremia group showed worse CGA scores in comparison with moderate and mild. With improvement in sodium level, the improvements in ADL, TUG, and HMSE scores were greater in the hyponatremia group (8.8 ± 10.1, 2.2 ± 2.5, and 1.7 ± 2.3 respectively) in comparison to the normonatremia reference group (4.7 ± 9.0, 1 ± 2.0, and 0.7 ± 1.3 respectively, P < 0.05).

Conclusion

Our study is the first utilizing HMSE to assess change in cognitive ability with improvement in serum sodium levels in the Indian elderly. Hyponatremic patients show worse baseline CGA parameters, and hyponatremia severity correlates with worse motor and cognitive function. Improvement in the serum sodium level improves the CGA parameters. Correction of hyponatremia in the geriatric age group significantly impacts life quality.
Appendix
Available only for authorised users
Literature
12.
14.
go back to reference Verbalis JG, Ellison H, Hobart M, Krasa H, Ouyang J, Czerwiec FS et al. (2016) Tolvaptan and neurocognitive function in mild to moderate chronic hyponatremia: A Randomized Trial (INSIGHT). Am J Kidney Dis [Internet]. [cited 2021 May 27];67(6):893–901. Available from: https://pubmed.ncbi.nlm.nih.gov/26874645/ Verbalis JG, Ellison H, Hobart M, Krasa H, Ouyang J, Czerwiec FS et al. (2016) Tolvaptan and neurocognitive function in mild to moderate chronic hyponatremia: A Randomized Trial (INSIGHT). Am J Kidney Dis [Internet]. [cited 2021 May 27];67(6):893–901. Available from: https://​pubmed.​ncbi.​nlm.​nih.​gov/​26874645/​
Metadata
Title
Serum sodium improvement: change in Comprehensive Geriatric Assessment parameters in geriatric patients with hyponatremia
Authors
M. Kapoor
M. Pathania
M. Dhar
Publication date
01-12-2023
Publisher
BioMed Central
Published in
BMC Geriatrics / Issue 1/2023
Electronic ISSN: 1471-2318
DOI
https://doi.org/10.1186/s12877-023-04299-x

Other articles of this Issue 1/2023

BMC Geriatrics 1/2023 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine